| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/12/2005 | EP1299724A4 Synthetic peptide for neurological disorders |
| 01/12/2005 | EP1233023B1 Transcription factor and dna thereof |
| 01/12/2005 | EP1227734B1 Compositions comprising edible oils or fats and phytosterols and/or phytostanols dissolved therein |
| 01/12/2005 | EP1226212A4 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 01/12/2005 | EP1143992B1 Therapeutic compositions containing glutathione analogs |
| 01/12/2005 | EP1083930A4 Insulin supplemented infant formula |
| 01/12/2005 | EP1019026B1 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 01/12/2005 | EP1002082B1 Transcriptional silencer protein nrf |
| 01/12/2005 | EP0996461B1 Use of a complement activation inhibitor in the manufacture of a medicament for inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| 01/12/2005 | EP0996460B1 Treatment of kidney fibrosis with antibodies against integrin alpha-v-beta 6 |
| 01/12/2005 | EP0956029B1 Cyclic peptides having broad spectrum antimicrobial activity |
| 01/12/2005 | EP0891428B1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/12/2005 | EP0848753B1 Nucleic acid molecule encoding tgf receptor having modified growth inhibition, and its use |
| 01/12/2005 | EP0770088B1 Novel cytokine designated lerk-5 |
| 01/12/2005 | EP0710251B1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 01/12/2005 | EP0627923B1 Therapeutic domains of von willebrand factor |
| 01/12/2005 | EP0568575B1 Test and model for alzheimer's disease |
| 01/12/2005 | CN1564828A Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/12/2005 | CN1564826A Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 01/12/2005 | CN1564696A Compositions for and methods of treating and preventing sirs/sepsis |
| 01/12/2005 | CN1564693A Methods of treating liver fibrosis and hepatitis C virus infection |
| 01/12/2005 | CN1564680A Biodegradable polymeric nanocapsules and uses thereof |
| 01/12/2005 | CN1564678A Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 01/12/2005 | CN1563970A Cholesterin test strip of electrochemical sensor and prepn. process of used reagent |
| 01/12/2005 | CN1563404A Method for preparing decrease blood pressure peptide 'Angiotensin I-converting enzyme inhibitor' of rice bran protein |
| 01/12/2005 | CN1563391A Recombined expression vector of restraining multiplication of leukemia cell |
| 01/12/2005 | CN1563388A Constructing genetic engineering Vaccine of adhesin of confluent Helicobacter pylor and preparation method |
| 01/12/2005 | CN1563387A Gene of earthworm plasmin and genetic engineerng strain, construction and application |
| 01/12/2005 | CN1563381A Deactivated protein gene in ribosome of motherwort |
| 01/12/2005 | CN1563370A Antiplasmin of Verticillium lecanii, preparation method and usage |
| 01/12/2005 | CN1563368A Nano superoxide dismutase and preparation method |
| 01/12/2005 | CN1563367A Defibrase modified by carbowax |
| 01/12/2005 | CN1563353A Strain of Pichia yeast genetic engineering, preparation method and application |
| 01/12/2005 | CN1563087A Polypeptide of ramification of ciliary nerves nutrilite for curing obesity |
| 01/12/2005 | CN1563079A Adherence peptide specific to tissue of liver cancer obtained through sieve method in vitro, and usage |
| 01/12/2005 | CN1563078A Adherence peptide specific to tissue of liver cancer, screen method combined between in vivo and in vitro, and usage |
| 01/12/2005 | CN1563077A Adherence peptide specific to tissue of liver cancer obtained through sieve method in rivo, and usage |
| 01/12/2005 | CN1563076A Alpha-MSH analog for curing sexual disorder and preparation method |
| 01/12/2005 | CN1562363A Polypeptide vaccine of free from adjuvant for anti human chorionic gonadotrophin and preparation method |
| 01/12/2005 | CN1562360A Enteric-coated capsule of compound proteolytic enzyme |
| 01/12/2005 | CN1562359A Capsules of multienzyme combination |
| 01/12/2005 | CN1562358A Peroral enteric coated capsule of defibrase |
| 01/12/2005 | CN1562357A Medication use for external application of glucose-insulin-potassium polarization liquid for curing trauma and burn |
| 01/12/2005 | CN1562356A Biological degradable macromolecule microspheres of carrying insulin and preparation method |
| 01/12/2005 | CN1562355A Method for preparing injection without needle of interferon |
| 01/12/2005 | CN1562354A Method for controlling mammal to give birth of female mammal based on H-Y antigen |
| 01/12/2005 | CN1562353A Usage of differentiation protein of medullary cell MyD88 in preparing medicinal preparation |
| 01/12/2005 | CN1562352A Technique for producing injection of freeze drying powder of A type botulinus toxin in use for treatment, and formula of protectant of freeze drying powder |
| 01/12/2005 | CN1562351A Application of agglutinin II protein of rhizome of manyflower solmonaeal in pharmacy |
| 01/12/2005 | CN1562350A Agglutinin II protein of rhizome of king solomonseal, and application |
| 01/12/2005 | CN1562349A Bacterin of nucleic acid for anti atherosclerosis and preparation method |
| 01/12/2005 | CN1562348A LHRH-agonist for treating infecundity |
| 01/12/2005 | CN1562347A Method for preparing granule of colistin sulphuric acid |
| 01/12/2005 | CN1562346A Compound preparation of cyclicamp or its ramification and counteractant for free radical |
| 01/12/2005 | CN1562345A Drug combination including activator for metabolism of brain and free radical scavenger |
| 01/12/2005 | CN1562344A Application of laevorotation carnosine in preparaing medication for assistant curing hepatitis and health foods |
| 01/12/2005 | CN1562343A Compound preparation of Azithromycin and Pidotimod |
| 01/12/2005 | CN1562342A Compound preparation of valvciclovir HCL and Pidotimod |
| 01/12/2005 | CN1562341A Left ofloxacin and Pidotimod compound preparation |
| 01/12/2005 | CN1562340A Method for preparing technical product of lowering sugar of balsam pear containing active protein |
| 01/12/2005 | CN1562339A Method for preparing pharmaceutics of hydrolysate of brain protein |
| 01/12/2005 | CN1562073A Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/12/2005 | CN1562069A Use of C-ski gene and its polypeptide in preparing medicine for improving tissue repairing and reducing scar formation |
| 01/12/2005 | CN1184321C Adenovirus-mediated gene therapy |
| 01/12/2005 | CN1184320C Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/12/2005 | CN1184317C Modifying method and application of exilis protein gene |
| 01/12/2005 | CN1184315C Death domain containing receptor 5 |
| 01/12/2005 | CN1184313C Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 01/12/2005 | CN1184234C Preparation of stable zinc insulin analog crystals |
| 01/12/2005 | CN1184233C Erytrocyte-stimulating factor coupling |
| 01/12/2005 | CN1184232C Human tumor necrosin relative death inducing ligand mutein and its prepn process and medicine composition |
| 01/12/2005 | CN1183972C Wound covering material capable of promoting wound healing |
| 01/12/2005 | CN1183966C Application of human urokininogenase in preparing medicine for preventing and treating cerebral infraction |
| 01/12/2005 | CN1183965C Nasal calcitonin formulations |
| 01/12/2005 | CN1183964C Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
| 01/12/2005 | CN1183963C Method for treatment of patients afflicted with multile sclerosis using consensus interferon |
| 01/12/2005 | CN1183962C Preparation capable of mobilization of activity |
| 01/12/2005 | CN1183961C Remedies for bone metabolic errors |
| 01/12/2005 | CN1183960C Use of bifidobacterium cell wall and bifidobacterium cell wall protein in pharmacy |
| 01/12/2005 | CN1183959C Tumor suppressing polypeptide TSF and gene therapy vector composition |
| 01/12/2005 | CN1183901C Pharmaceutical compositions capable of being gelled |
| 01/11/2005 | US6841701 Inhibitors for the blood-clotting factor Xa |
| 01/11/2005 | US6841662 Nucleotide sequences coding enzymatic polypeptide for use in the human dietics, cosmetics and therapeutics |
| 01/11/2005 | US6841661 Glycopeptide antibacterial compounds, compositions containing same and methods of using same |
| 01/11/2005 | US6841658 Isolating preferential polypeptide; obtain sample, incubate with ion exchange resin, elute, recover polypeptide |
| 01/11/2005 | US6841657 Inhibitors of HIV membrane fusion |
| 01/11/2005 | US6841617 Thermogelling biodegradable aqueous polymer solution |
| 01/11/2005 | US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/11/2005 | US6841561 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 01/11/2005 | US6841543 Contacting a human immune cell with a sufficient amount of a pharmaceutical composition consisting essentially of non-crosslinked, monovalent Lewisx antigen consisting of LNFP-III lacto-N-fucopentaose III |
| 01/11/2005 | US6841542 Transforming growth factor beta (TGF-β) blocking agent-treated stem cell composition and method |
| 01/11/2005 | US6841534 For inhibiting blood coagulation |
| 01/11/2005 | US6841533 Overcoming the drawbacks of the native peptide molecules (low metabolic stability, poor oral bio-availability, rapid liver and kidney excretion, and lack of selectivity), thereby providing improved therapeutic properties |
| 01/11/2005 | US6841532 Peptides and their use to ameliorate cell death |
| 01/11/2005 | US6841531 For promoting the survival, growth, proliferation, or maintenance of mammalian neurons; accelerating wound healing while minimizing or inhibiting scar formation and keloid formation |
| 01/11/2005 | US6841530 Semi-synthetic studies toward didemnin analogues |
| 01/11/2005 | US6841385 Transcription factor E2F DNA-binding domain inhibitor peptides and their use |
| 01/11/2005 | US6841381 Immunization by inoculation of DNA transcription unit |
| 01/11/2005 | US6841371 Comprises anticoagulant polypeptide for treatment and prevention of acute coronary syndromes, vascular occlusive disorders and thrombosis |